- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02164201
Post Market Surveillance Study Evaluating BioFoam Surgical Matrix in Cardiovascular Surgery
Post Market Surveillance Study Evaluating the Operative Management of Anastomotic Bleeding by Means of an Adjunctive Application of BioFoam Surgical Matrix in Cardiovascular Surgery
This is a prospective, multicenter, single-arm study designed to collect clinical data to support the safety and effectiveness of BioFoam used as a surgical adjunct to anastomotic hemostasis following cardiovascular surgery.
The overall objective of this clinical study is to collect clinical data supporting the safety and effectiveness of BioFoam used as a surgical adjunct to anastomotic hemostasis following cardiovascular surgery. This study is intended as a post-market surveillance (follow-up) study.
Studieoversikt
Status
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Patients undergoing cardiac or cardiovascular procedures, including, but not limited to:
Thoracic Aortic Aneurysm Aortic Valve Replacement Type A Aortic Dissection (where BioFoam is limited to the anastomotic site)
Beskrivelse
Inclusion Criteria:
- Subject is undergoing an elective cardiac or cardiovascular procedure;
- Subject is willing and able to give prior written informed consent for investigation participation; and
- Subject is > 18 years of age.
Intraoperative inclusion criteria include:
• Subject that requires the use of an adjunctive surgical hemostatic agent to the repair site to control generalized oozing following standard repair procedures (such as sutures and staples).
Exclusion Criteria:
• Subject with known hypersensitivity to albumin, bovine products, or glutaraldehyde;
- Subject with active infection (either systemic or in the repair region);
- Subject whose pathology or underlying disease state makes them an unacceptable candidate for a clinical investigation in the opinion of the Investigator;
- Subject diagnosed with a coagulation disorder;
- Subject with abnormal calcium metabolism (e.g., chronic renal failure, hyperparathyroidism);
- Subject whose life expectancy is less than that required for the prescribed follow-up duration;
- Subject who is pregnant, planning on becoming pregnant during the follow-up period, or actively breast-feeding; or
- Subject who is immunocompromised.
Intraoperative exclusion criteria include:
• Any major intraoperative bleeding incidences (i.e., American College of Surgeons Advanced Trauma Life Support Class II, III, or IV Hemorrhage).
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
Achievement of haemostasis
Tidsramme: 3 minutes after application
|
3 minutes after application
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
---|---|
Time to haemostasis
Tidsramme: measured through to 10 minutes
|
measured through to 10 minutes
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Bernhard Voss, PD Dr Med, Deutsches Herzzentrum Muenchen
- Hovedetterforsker: Ottavio Alfieri, Professor, San Raffale Hospital
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- BFM1301.000-M
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Thoracic aortaaneurisme
-
IRCCS Policlinico S. DonatoRekrutteringAnomalous aortic origin of the coronary artery (AAOCA)Italia
-
Mahidol UniversityFullført
-
University of VirginiaFullførtThoracicForente stater
-
Tanta UniversityFullført
-
Tanta UniversityFullført
-
Hospices Civils de LyonFullførtKirurgi | ThoracicFrankrike
-
Association Pro-arteUniversity Hospital, GrenobleFullført
-
Medtronic CardiovascularMedtronicAvsluttetThoracic aortaaneurismerForente stater
-
Christopher McKeeAvsluttet